ATLASATLAS fair value
SEK 8.05
Above fair value · 168% premium
Range: SEK 6.56–SEK 9.88Fair valuePrice
Genovis AB (publ.) (GENO.ST)
Genovis AB (publ.) stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · Nasdaq Stockholm · Sweden
SEK 21.60▲ +3.10%
Prices as of Oct 27, 2026 · SEK
Chance of rising in 1 month
50%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Genovis AB (publ.) in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Genovis AB (publ.)
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Genovis AB (publ.)'s fair value at about SEK 8.05 per share (reasonable range: SEK 6.56 to SEK 9.88). At SEK 21.60, the stock trades 168% above it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Genovis AB (publ.) a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between SEK 20.12 and SEK 23.14; in 9 out of 10, between SEK 17.77 and SEK 26.20. Estimated annual volatility is 35%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- SEK 1.3B
- Market cap (USD)
- $134M
- P/E ratio
- 68.8
- 52-week high
- SEK 23.65
- 52-week low
- SEK 15.64
- Revenue (12 months)
- SEK 136M
- Gross margin
- 88.6%
- Operating margin
- 9.4%
- Net margin
- 15.1%
- Beta
- 1.76
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Genovis AB (publ.) sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks GENO.ST has traded between SEK 15.64 and SEK 23.65. Today it is 8.7% below that high and 38% above its low.
On the business: net margin is 15.1%; it trades at 68.8 times earnings.
Its beta is 1.76: it tends to move more than the market, both up and down.
About the company
) develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
Want to see everything about Genovis AB (publ.)?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Genovis AB (publ.) (GENO.ST) fair value?
About SEK 8.05 per share according to ATLAS (reasonable range: SEK 6.56 to SEK 9.88). With the stock at SEK 21.60, it is 168% above it.
What is the chance GENO.ST goes up next month?
50%: close to a coin flip. In half of the simulated outcomes, GENO.ST ends the month between SEK 20.12 and SEK 23.14.
How big is Genovis AB (publ.) and what is its P/E ratio?
Genovis AB (publ.)'s market capitalization is SEK 1.3B. Its price-to-earnings (P/E) ratio is 68.8: you pay SEK 68.8 for each SEK 1.00 of yearly earnings.
How volatile is GENO.ST?
ATLAS estimates annual volatility at 35%. In a typical month, half of the outcomes end between SEK 20.12 and SEK 23.14.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer